Sugerencias
Idioma
Guía para autores
Buscador
Información de la revista
Vol. 1. Núm. 4.
Páginas 183-235 (Noviembre - Diciembre 2005)
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Vol. 1. Núm. 4.
Páginas 183-235 (Noviembre - Diciembre 2005)
Editorial
Acceso a texto completo

Síndrome antifosfolipídico: nuevas perspectivas clínicas y terapéuticas

Visitas
90040
R. Cerveraa,
Autor para correspondencia
rcervera@clinic.ub.es

Correspondencia: Dr. R. Cervera. Servicio de Enfermedades Autoinmunes. Hospital Clínic. Villarroel, 170. 08036 Barcelona. España.
, R.A. Ashersonb
a Servicio de Enfermedades Autoinmunes. Hospital Clínic. Barcelona. España
b Rheumatic Diseases Unit. University of Cape Town Faculty of Health Sciences. Ciudad del Cabo. Sudáfrica
Este artículo ha recibido
Información del artículo
PDF
El Texto completo está disponible en PDF
Bibliografía
[1.]
G.R.V. Hughes.
Thrombosis, abortion, cerebral disease and the lupus anticoagulant.
Br Med J, 287 (1983), pp. 1088-1089
[2.]
The antiphospholipid syndrome II-Autoimmune Thrombosis,
[3.]
W.A. Wilson, A.E. Gharavi, T. Koike, et al.
International Consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an International Workshop.
[4.]
R.A. Asherson, R. Cervera, P.G. De Groot, et al.
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines.
Lupus, 12 (2003), pp. 530-534
[5.]
Miyakis S, Lockshin MD, Atsumi T, et al. Summary of the international consensus statement on an update of the preliminary classification criteria for antiphospholipid syndrome (APS). J J Thromb Haemostas. En prensa 2005.
[6.]
R. Cervera, M.A. Khamashta, J. Font, et al.
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients.
Medicine (Baltimore), 72 (1993), pp. 113-124
[7.]
J. Balasch, J. Font, A. López-Soto, et al.
Antiphospholipid antibodies in unselected patients with repeated abortion.
Hum Reprod, 5 (1990), pp. 43-46
[8.]
R. Cervera, J.C. Piette, J. Font, et al.
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
Arthritis Rheum, 46 (2002), pp. 1019-1027
[9.]
R.A. Asherson.
The catastrophic antiphospholipid antibody syndrome [editorial].
J Rheumatol, 19 (1992), pp. 508-512
[10.]
R.A. Asherson, R. Cervera, J.C. Piette, et al.
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
Medicine (Baltimore), 77 (1998), pp. 195-207
[11.]
R.A. Asherson, R. Cervera, J.C. Piette, et al.
Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients.
Medicine (Baltimore), 80 (2001), pp. 355-376
[12.]
D. Alarcón-Segovia, M.C. Boffa, W. Branch, et al.
Prophylaxis of the antiphospholipid syndrome: a consensus report.
Lupus, 12 (2003), pp. 499-503
[13.]
P.L. Meroni, M. Moia, R.H.W.M. Derksen, et al.
Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis.
Lupus, 12 (2003), pp. 504-507
[14.]
R.L. Brey, J. Chapman, S.R. Levine, et al.
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002.
Lupus, 12 (2003), pp. 508-513
[15.]
J. Chapman, J.H. Rand, R.L. Brey, et al.
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.
Lupus, 12 (2003), pp. 514-517
[16.]
M. Lockshin, F. Tenedios, M. Petri, et al.
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report.
Lupus, 12 (2003), pp. 518-523
[17.]
A. Tincani, W. Branch, R.A. Levy, et al.
Treatment of pregnant patients with antiphospholipid syndrome.
Lupus, 12 (2003), pp. 524-529
[18.]
M.A. Khamashta, M.J. Cuadrado, F. Mujic, N.A. Taub, B.J. Hunt, G.R.V. Hughes.
The management of thrombosis in the antiphospholipid antibody syndrome.
N Engl J Med, 332 (1995), pp. 993-997
[19.]
M.A. Crowther, J.S. Ginsberg, J. Julian, et al.
A comparison of two intensities of warfarin in the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome.
N Engl J Med, 349 (2003), pp. 1133-1138
[20.]
F. Carmona, J. Font, M. Azulay, et al.
Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis.
Am J Reprod Immunol, 46 (2001), pp. 274-279
[21.]
M. Blank, R.A. Asherson, R. Cervera, Y. Shoenfeld.
Antiphospholipid syndrome infectious origin.
J Clin Immunol, 24 (2004), pp. 12-23
Copyright © 2005. Elsevier España S.L. Barcelona
Descargar PDF
Idiomas
Reumatología Clínica
Opciones de artículo
Herramientas